Sasol Shelves Louisiana Investment

Related Link: 

Sasol said it was shelving an $11 billion project on Louisiana’s Gulf Coast, imperiling one of the largest foreign investments on U.S. soil because of the plunge in oil prices.

Facebook Earnings Rise on Mobile Growth

Related Link: 

Facebook’s earnings jumped 34% in the holiday quarter, despite an 87% increase in costs, as the social network continues to get more money from mobile ads.

Pentagon Picks Boeing 747-8 As New Presidential Aircraft

Related Link: 

The Pentagon said it had selected Boeing’s 747-8 to replace the aircraft that serves as Air Force One for the president of the U.S.

Fiat Chrysler Turns Corner in Europe

Related Link: 

The Italian-American car maker forecast a jump of as much as 41% in operating profit this year and said it expects to generate its first full-year profit in hard-hit Europe for the first time in seven years.

Fed Sticks to 'Patient' Tack on Rate Increases

Related Link: 

The Federal Reserve on Wednesday committed to keeping short-term interest rates near zero at least until midyear and set the stage for tough debates in the months ahead about whether to wait even longer.

Drone Maker to Prevent Some Device Flights Over D.C.

Related Link: 

In response to the drone crash at the White House this week, the Chinese maker of the device that crashed said it is updating its drones to disable them from flying over much of Washington, D.C.

On-Demand Workers: 'We Are Not Robots'

Related Link: 

Companies that rely on freelance labor describe their workers as micro-entrepreneurs. But lawsuits, protests and forums suggest that many flexible laborers feel less enthusiastic about the new work model.

Startups See Your Face, Unmask Your Emotions

Related Link: 

Startups with names like Emotient and Affectiva are combining psychology and algorithms to analyze people’s faces and potentially discover their deepest feelings. Collectively, they are amassing an enormous visual database and breeding privacy concerns.

EU Approves Novartis-Glaxo Deals

Related Link: 

The drug giants won European Union regulatory approval for a complicated series of deals worth more than $20 billion that will focus Novartis’ scope and turn Glaxo into a vaccines-and-consumer-drug powerhouse.

China, Alibaba Clash Over Fake Goods

Related Link: 

Alibaba is embroiled in a rare, high-stakes public dispute with a Chinese government agency over fake goods sales on its e-commerce platforms, highlighting one of the risks for a company that last year raised $25 billion in the world’s largest IPO.

Syndicate content